ClinicalTrials.gg
Drug

Acoltremon clinical trials

Also written TRYPTYR®.

studies test it
18
open now
10
in phase 3
6
first study started
2017

How each study uses acoltremon is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the acoltremon studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
28 May 2025 · TRYPTYR · NDA 217370 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

0.003% AR-15512 ophthalmic solution
6
Acoltremon ophthalmic solution 0.003%
4
acoltremon 0.003%
4
TRYPTYR (Acoltremon ophthalmic solution 0.003%)
2
Acoltremon
1

Brand

TRYPTYR®
4

Studies by the year they started

18 studies that test it; most in 2025 (6)

Studies that test acoltremon, by start year
YearStudies
20171
20201
20223
20242
20256
20265

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
2
Phase 3
6
Phase 4
10

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 8 · Other 10

Aerie Pharmaceuticals (4) · Southern College of Optometry (4) · Alcon Research (3) · University of California, Berkeley (1) · Eye Research Associates, LLC (1) · University of South Florida (1) · Center for Sight Las Vegas (1) · NYU Langone Health (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 7

Studies that test acoltremon.

Studies

Open first, then newest update. How each study uses acoltremon is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 18

What changed recently

From the registry's own updates since Oct 20, 2026.

Newly registered2

Codes

What other systems call acoltremon · ClinicalTrials.gg INT002150

  • MeSH (NLM) C000731855acoltremonOne source NLM
  • UNII (FDA) 1L7BVT4Z4ZACOLTREMONConfirmed FDA, NLM, Wikidata
  • Wikidata Q27089230acoltremonConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C189962AcoltremonOne source FDA
  • DrugBank DB19202One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.